Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats

Journal of Proteome Research

Volumn 11, Issue 8, 2012, Pages 4315-4325

  Stoop, Marcel P ^a   Rosenling, Therese ^b   Attali, Amos ^c   Meesters, Roland J W ^a   Stingl, Christoph ^a   Dekker, Lennard J ^a   Van Aken, Hans ^c   Suidgeest, Ernst ^c   Hintzen, Rogier Q ^a   Tuinstra, Tinka ^c   Van Gool, Alain ^d,e   Luider, Theo M ^a   Bischoff, Rainer ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c Chemical Design and Synthesis Unit   (Netherlands)

^d MERCK RESEARCH LABORATORIES   (United States)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

cerebrospinal fluid; experimental autoimmune encephalomyelitis; minocycline; multiple sclerosis; proteomics; selected reaction monitoring

Indexed keywords

CARBOXYPEPTIDASE; COMPLEMENT COMPONENT C3; MINOCYCLINE; PROTEOME;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RAT; TANDEM MASS SPECTROMETRY; TREATMENT RESPONSE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CARBOXYPEPTIDASE B; CEREBROSPINAL FLUID PROTEINS; COMPLEMENT C3; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FREUND'S ADJUVANT; MALE; MINOCYCLINE; MULTIPLE SCLEROSIS; NEUROPROTECTIVE AGENTS; PROTEOME; RATS; RATS, INBRED LEW; TANDEM MASS SPECTROMETRY;

ANIMALIA; RATTUS;

EID: 84864622005     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300428e     Document Type: Article

References (43)

1. Weinstock-Guttman, B.; Cohen, J. A. Newer versus older treatments for relapsing-remitting multiple sclerosis Drug Saf. 1996, 14 (2) 121-130 (Pubitemid 26048779)
2. Compston, A.; Coles, A. Multiple sclerosis Lancet 2008, 372 (9648) 1502-1517
3. Brundula, V.; Rewcastle, N. B.; Metz, L. M.; Bernard, C. C.; Yong, V. W. Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis Brain 2002, 125 (Part 6) 1297-1308 (Pubitemid 34587139)
4. Du, Y.; Ma, Z.; Lin, S.; Dodel, R. C.; Gao, F.; Bales, K. R.; Triarhou, L. C.; Chernet, E.; Perry, K. W.; Nelson, D. L.; Luecke, S.; Phebus, L. A.; Bymaster, F. P.; Paul, S. M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (25) 14669-14674 (Pubitemid 33121449)
5. Metz, L. M.; Li, D.; Traboulsee, A.; Myles, M. L.; Duquette, P.; Godin, J.; Constantin, M.; Yong, V. W.; investigators, G. A. m. s. Glatiramer acetate in combination with minocycline in patients with relapsing-remitting multiple sclerosis: Results of a Canadian, multicenter, double-blind, placebo-controlled trial Mult. Scler. 2009, 15 (10) 1183-1194
6. Metz, L. M.; Zhang, Y.; Yeung, M.; Patry, D. G.; Bell, R. B.; Stoian, C. A.; Yong, V. W.; Patten, S. B.; Duquette, P.; Antel, J. P.; Mitchell, J. R. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis Ann. Neurol. 2004, 55 (5) 756 (Pubitemid 38544341)
7. Zabad, R. K.; Metz, L. M.; Todoruk, T. R.; Zhang, Y.; Mitchell, J. R.; Yeung, M.; Patry, D. G.; Bell, R. B.; Yong, V. W. The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: A pilot study Mult. Scler. 2007, 13 (4) 517-526 (Pubitemid 46796512)
8. Zhang, Y.; Metz, L. M.; Yong, V. W.; Bell, R. B.; Yeung, M.; Patry, D. G.; Mitchell, J. R. Pilot study of minocycline in relapsing-remitting multiple sclerosis Can. J. Neurol. Sci. 2008, 35 (2) 185-191 (Pubitemid 351831055)
9. Kim, H. S.; Suh, Y. H. Minocycline and neurodegenerative diseases Behav. Brain Res. 2009, 196 (2) 168-179
10. Leonardo, C. C.; Eakin, A. K.; Ajmo, J. M.; Collier, L. A.; Pennypacker, K. R.; Strongin, A. Y.; Gottschall, P. E. Delayed administration of a matrix metalloproteinase inhibitor limits progressive brain injury after hypoxia-ischemia in the neonatal rat J. Neuroinflammation 2008, 5, 34
11. Mishra, M. K.; Dutta, K.; Saheb, S. K.; Basu, A. Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: Correlation with minocycline administration as a therapeutic agent Neurochem. Int. 2009, 55 (8) 717-723
12. Ohshima, S.; Fujimoto, S.; Petrov, A.; Nakagami, H.; Haider, N.; Zhou, J.; Tahara, N.; Osako, M. K.; Fujimoto, A.; Zhu, J.; Murohara, T.; Edwards, D. S.; Narula, N.; Wong, N. D.; Chandrashekhar, Y.; Morishita, R.; Narula, J. Effect of an antimicrobial agent on atherosclerotic plaques: Assessment of metalloproteinase activity by molecular imaging J. Am. Coll. Cardiol. 2010, 55 (12) 1240-1249
13. Yong, V. W.; Zabad, R. K.; Agrawal, S.; Goncalves Dasilva, A.; Metz, L. M. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators J. Neurol. Sci. 2007, 259 (1-2) 79-84 (Pubitemid 47031205)
14. Yong, V. W.; Giuliani, F.; Xue, M.; Bar-Or, A.; Metz, L. M. Experimental models of neuroprotection relevant to multiple sclerosis. Neurology 2007, 68 (22 Suppl. 3), S32-S37; discussion S43-S54.
15. Luccarini, I.; Ballerini, C.; Biagioli, T.; Biamonte, F.; Bellucci, A.; Rosi, M. C.; Grossi, C.; Massacesi, L.; Casamenti, F. Combined treatment with atorvastatin and minocycline suppresses severity of EAE Exp. Neurol. 2008, 211 (1) 214-226
16. Popovic, N.; Schubart, A.; Goetz, B. D.; Zhang, S. C.; Linington, C.; Duncan, I. D. Inhibition of autoimmune encephalomyelitis by a tetracycline Ann. Neurol. 2002, 51 (2) 215-223 (Pubitemid 34111444)
17. Defaux, A.; Zurich, M. G.; Honegger, P.; Monnet-Tschudi, F. Minocycline promotes remyelination in aggregating rat brain cell cultures after interferon-gamma plus lipopolysaccharide-induced demyelination Neuroscience 2011, 187, 84-92
18. Rosenling, T.; Stoop, M. P.; Attali, A.; Aken, H. V.; Suidgeest, E.; Christin, C.; Stingl, C.; Suits, F.; Horvatovich, P.; Hintzen, R. Q.; Tuinstra, T.; Bischoff, R.; Luider, T. M. Profiling and Identification of Cerebrospinal Fluid Proteins in a Rat EAE Model of Multiple Sclerosis J. Proteome Res. 2012, 11, 2048-2060
19. Olsen, J. V.; de Godoy, L. M.; Li, G.; Macek, B.; Mortensen, P.; Pesch, R.; Makarov, A.; Lange, O.; Horning, S.; Mann, M. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap Mol. Cell Proteomics 2005, 4 (12) 2010-2021 (Pubitemid 41830195)
20. Meesters, R. J.; Cornelissen, R.; van Klaveren, R. J.; de Jonge, R.; den Boer, E.; Lindemans, J.; Luider, T. M. A new ultrafast and high-throughput mass spectrometric approach for the therapeutic drug monitoring of the multi-targeted anti-folate pemetrexed in plasma from lung cancer patients Anal. Bioanal. Chem. 2010, 398 (7-8) 2943-2948
21. Avolio, C.; Ruggieri, M.; Giuliani, F.; Liuzzi, G. M.; Leante, R.; Riccio, P.; Livrea, P.; Trojano, M. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes J. Neuroimmunol. 2003, 136 (1-2) 46-53 (Pubitemid 36298843)
22. Benesova, Y.; Vasku, A.; Novotna, H.; Litzman, J.; Stourac, P.; Beranek, M.; Kadanka, Z.; Bednarik, J. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis Mult. Scler. 2009, 15 (3) 316-322
23. Fainardi, E.; Castellazzi, M.; Tamborino, C.; Trentini, A.; Manfrinato, M. C.; Baldi, E.; Tola, M. R.; Dallocchio, F.; Granieri, E.; Bellini, T. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis Mult. Scler. 2009, 15 (5) 547-554
24. Kilinc, M.; Saatci-Cekirge, I.; Karabudak, R. Serial analysis of soluble intercellular adhesion molecule-1 level in relapsing-remitting multiple sclerosis patients during IFN-beta1b treatment J. Interferon Cytokine Res. 2003, 23 (3) 127-133 (Pubitemid 36408143)
25. Lee, S. J.; Benveniste, E. N. Adhesion molecule expression and regulation on cells of the central nervous system J. Neuroimmunol. 1999, 98 (2) 77-88 (Pubitemid 29317533)
26. Morini, M.; Roccatagliata, L.; Dell'Eva, R.; Pedemonte, E.; Furlan, R.; Minghelli, S.; Giunti, D.; Pfeffer, U.; Marchese, M.; Noonan, D.; Mancardi, G.; Albini, A.; Uccelli, A. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis J. Neuroimmunol. 2004, 148 (1-2) 146-153 (Pubitemid 38229567)
27. Prince, H. E. Biomarkers for diagnosing and monitoring autoimmune diseases Biomarkers 2005, 10 (Suppl. 1) S44-S49
28. Song, J. J.; Hwang, I.; Cho, K. H.; Garcia, M. A.; Kim, A. J.; Wang, T. H.; Lindstrom, T. M.; Lee, A. T.; Nishimura, T.; Zhao, L.; Morser, J.; Nesheim, M.; Goodman, S. B.; Lee, D. M.; Bridges, S. L., Jr.; Consortium for the Longitudinal Evaluation of African Americans with Early Rheumatoid Arthritis (CLEAR) Registry; Gregersen, P. K.; Leung, L. L.; Robinson, W. H. Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis J. Clin. Invest. 2011, 121 (9) 3517-3527
29. Fan, J.; Liu, J.; Culty, M.; Papadopoulos, V. Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): An emerging signaling molecule Prog. Lipid Res. 2010, 49 (3) 218-234
30. Oku, M.; Tanakura, S.; Uemura, A.; Sohda, M.; Misumi, Y.; Taniguchi, M.; Wakabayashi, S.; Yoshida, H. Novel cis-acting element GASE regulates transcriptional induction by the Golgi stress response Cell Struct. Funct. 2011, 36 (1) 1-12
31. Bausch, D.; Thomas, S.; Mino-Kenudson, M.; Fernandez-del, C. C.; Bauer, T. W.; Williams, M.; Warshaw, A. L.; Thayer, S. P.; Kelly, K. A. Plectin-1 as a novel biomarker for pancreatic cancer Clin. Cancer Res. 2011, 17 (2) 302-309
32. Dietzschold, B.; Schwaeble, W.; Schafer, M. K.; Hooper, D. C.; Zehng, Y. M.; Petry, F.; Sheng, H.; Fink, T.; Loos, M.; Koprowski, H.; Weihe, E. Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis J. Neurol. Sci. 1995, 130 (1) 11-16
33. Liu, T.; Donahue, K. C.; Hu, J.; Kurnellas, M. P.; Grant, J. E.; Li, H.; Elkabes, S. Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord J. Proteome Res. 2007, 6 (7) 2565-2575 (Pubitemid 47122351)
34. Stoop, M. P.; Dekker, L. J.; Titulaer, M. K.; Lamers, R. J.; Burgers, P. C.; Sillevis Smitt, P. A.; van Gool, A. J.; Luider, T. M.; Hintzen, R. Q. Quantitative matrix-assisted laser desorption ionization-fourier transform ion cyclotron resonance (MALDI-FT-ICR) peptide profiling and identification of multiple-sclerosis-related proteins J. Proteome Res. 2009, 8 (3) 1404-1414
35. McDonald, W. I.; Compston, A.; Edan, G.; Goodkin, D.; Hartung, H. P.; Lublin, F. D.; McFarland, H. F.; Paty, D. W.; Polman, C. H.; Reingold, S. C.; Sandberg-Wollheim, M.; Sibley, W.; Thompson, A.; van den Noort, S.; Weinshenker, B. Y.; Wolinsky, J. S. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis Ann. Neurol. 2001, 50 (1) 121-127
36. Villarroya, H.; Violleau, K.; Ben Younes-Chennoufi, A.; Baumann, N. Myelin-induced experimental allergic encephalomyelitis in Lewis rats: Tumor necrosis factor alpha levels in serum and cerebrospinal fluid immunohistochemical expression in glial cells and macrophages of optic nerve and spinal cord J. Neuroimmunol. 1996, 64 (1) 55-61
37. Reindl, M.; Knipping, G.; Wicher, I.; Dilitz, E.; Egg, R.; Deisenhammer, F.; Berger, T. Increased intrathecal production of apolipoprotein D in multiple sclerosis J. Neuroimmunol. 2001, 119 (2) 327-332 (Pubitemid 32918341)
38. Szmyrka-Kaczmarek, M.; Pokryszko-Dragan, A.; Pawlik, B.; Gruszka, E.; Korman, L.; Podemski, R.; Wiland, P.; Szechinski, J. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis Lupus 2012, 21, 412-420
39. Nikodemova, M.; Lee, J.; Fabry, Z.; Duncan, I. D. Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord J. Neuroimmunol. 2010, 219 (1-2) 33-37
40. Denic, A.; Johnson, A. J.; Bieber, A. J.; Warrington, A. E.; Rodriguez, M.; Pirko, I. The relevance of animal models in multiple sclerosis research Pathophysiology 2011, 18 (1) 21-29
41. Rosenling, T.; Attali, A.; Luider, T. M.; Bischoff, R. The experimental autoimmune encephalomyelitis model for proteomic biomarker studies: From rat to human Clin. Chim. Acta 2011, 412 (11-12) 812-822
42. Steinman, L.; Zamvil, S. S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis Ann. Neurol. 2006, 60 (1) 12-21
43. Elkabes, S.; Li, H. Proteomic strategies in multiple sclerosis and its animal models Proteomics Clin. Appl. 2007, 1 (11) 1393-1405